Baoxia Liang

1.2k total citations
26 papers, 769 citations indexed

About

Baoxia Liang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Baoxia Liang has authored 26 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Baoxia Liang's work include Synthesis and biological activity (4 papers), Redox biology and oxidative stress (4 papers) and Synthesis and Biological Evaluation (3 papers). Baoxia Liang is often cited by papers focused on Synthesis and biological activity (4 papers), Redox biology and oxidative stress (4 papers) and Synthesis and Biological Evaluation (3 papers). Baoxia Liang collaborates with scholars based in China, Singapore and United Kingdom. Baoxia Liang's co-authors include Zhenfeng Zhang, Xianzhang Bu, Jun Shen, Bihui Cao, Jun Du, Cuige Zhu, Xin Yue, Lu Wang, Yunfei Feng and Jinling Zhang and has published in prestigious journals such as Chemical Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Baoxia Liang

26 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baoxia Liang China 14 297 187 150 124 99 26 769
Pascal De Tullio Belgium 16 481 1.6× 139 0.7× 128 0.9× 90 0.7× 50 0.5× 43 1.1k
Jae Young So United States 18 447 1.5× 323 1.7× 80 0.5× 105 0.8× 170 1.7× 24 969
Simon Wing Fai Mok Macao 21 598 2.0× 205 1.1× 161 1.1× 75 0.6× 41 0.4× 35 1.0k
Samriddhi Shukla India 19 729 2.5× 208 1.1× 119 0.8× 56 0.5× 90 0.9× 26 1.1k
John F. Schindler United States 15 623 2.1× 149 0.8× 159 1.1× 151 1.2× 77 0.8× 21 992
Tianxin Yang China 21 671 2.3× 170 0.9× 55 0.4× 66 0.5× 62 0.6× 30 1.2k
Veena Somasundaram United States 19 348 1.2× 184 1.0× 88 0.6× 155 1.3× 30 0.3× 26 889
Sławomir Mańdziuk Poland 13 193 0.6× 256 1.4× 60 0.4× 53 0.4× 81 0.8× 62 703
Sung‐Po Hsu Taiwan 19 460 1.5× 163 0.9× 48 0.3× 82 0.7× 47 0.5× 41 870
Yang Sai China 17 427 1.4× 280 1.5× 50 0.3× 94 0.8× 42 0.4× 44 1.0k

Countries citing papers authored by Baoxia Liang

Since Specialization
Citations

This map shows the geographic impact of Baoxia Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoxia Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoxia Liang more than expected).

Fields of papers citing papers by Baoxia Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baoxia Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoxia Liang. The network helps show where Baoxia Liang may publish in the future.

Co-authorship network of co-authors of Baoxia Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Baoxia Liang. A scholar is included among the top collaborators of Baoxia Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baoxia Liang. Baoxia Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jinling, Xiaoliang Wu, Baoxia Liang, et al.. (2024). RP11-874 J12.4 promotes erlotinib resistance in non-small cell lung cancer via increasing AXL expression. Life Sciences. 351. 122849–122849. 5 indexed citations
2.
Shan, L. Y., et al.. (2024). A mobile double-suspension technology for single-port D2 distal gastrectomy: A technical note with video vignette. Asian Journal of Surgery. 48(5). 2933–2936. 1 indexed citations
3.
Liang, Baoxia, et al.. (2023). Novel Indole-Containing Hybrids Derived from Millepachine: Synthesis, Biological Evaluation and Antitumor Mechanism Study. Molecules. 28(3). 1481–1481. 8 indexed citations
4.
Cao, Bihui, Baoxia Liang, Manting Liu, et al.. (2021). Feasibility and safety of fine positioning needle-mediated breathing control in CT-guided percutaneous puncture of small lung/liver nodules adjacent to diaphragm. Scientific Reports. 11(1). 3411–3411. 8 indexed citations
5.
Huang, Shuai, Bihui Cao, Jinling Zhang, et al.. (2021). Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential. Cell Death and Disease. 12(3). 237–237. 79 indexed citations
6.
Yan, Jun, Xing Jin, Qiaoxuan Zhang, et al.. (2021). Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR. European Journal of Medicinal Chemistry. 227. 113897–113897. 36 indexed citations
7.
Cao, Bihui, Manting Liu, Jingjun Huang, et al.. (2021). Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer. International Journal of Biological Sciences. 17(14). 3850–3861. 71 indexed citations
8.
Wang, Xia, Huizhong Zhang, Baoxia Liang, et al.. (2020). High expression of folate cycle enzyme MTHFD1L correlates with poor prognosis and increased proliferation and migration in colorectal cancer. Journal of Cancer. 11(14). 4213–4221. 14 indexed citations
9.
Cao, Bihui, Manting Liu, Lu Wang, et al.. (2020). Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer. Biochemical and Biophysical Research Communications. 524(1). 96–102. 71 indexed citations
10.
Guo, Song‐Bin, et al.. (2020). Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway. Cancer Chemotherapy and Pharmacology. 85(6). 1097–1108. 31 indexed citations
11.
Wang, Sufan, Ting Wan, Mingtong Ye, et al.. (2018). Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway. Redox Biology. 17. 89–98. 135 indexed citations
12.
Liang, Baoxia, Ziyi Liu, Yingnan Cao, et al.. (2016). MC37, a new mono-carbonyl curcumin analog, induces G2/M cell cycle arrest and mitochondria-mediated apoptosis in human colorectal cancer cells. European Journal of Pharmacology. 796. 139–148. 34 indexed citations
13.
Huang, Lei, Yu Chen, Baoxia Liang, et al.. (2014). A furanyl acryl conjugated coumarin as an efficient inhibitor and a highly selective off–on fluorescent probe for covalent labelling of thioredoxin reductase. Chemical Communications. 50(53). 6987–6987. 38 indexed citations
14.
Liang, Baoxia, et al.. (2012). 3‐Nitro‐2H‐chromenes as a New Class of Inhibitors against Thioredoxin Reductase and Proliferation of Cancer Cells. Archiv der Pharmazie. 345(10). 767–770. 32 indexed citations
15.
Mei, Wenjie, et al.. (2008). Studies on cytotoxic and DNA-binding properties of two ruthenium(II) complexes of a substituted phenanthroline ligand. Transition Metal Chemistry. 33(4). 499–503. 13 indexed citations
16.
Shen, Jun, et al.. (2007). Morphologic analysis of normal human lumbar dorsal root ganglion by 3D MR imaging.. American Journal of Neuroradiology. 27(10). 2098–103. 68 indexed citations
17.
Newell, David R., Alan V. Boddy, Baoxia Liang, et al.. (2000). True. British Journal of Cancer. 82(9). 1519–1527. 4 indexed citations
18.
Liang, Baoxia, et al.. (1999). [Clinical study on preventive effect of taozhi zhipu mixture on postoperative intestinal adhesion].. PubMed. 19(5). 273–5. 2 indexed citations
19.
Liang, Baoxia, et al.. (1993). [Pregnancy after cardiac valve replacement: analysis of 21 cases].. PubMed. 28(7). 386–8, 440. 2 indexed citations
20.
Liang, Baoxia, et al.. (1992). [Diagnosis and management of obstetric acute disseminated intravascular coagulation].. PubMed. 27(3). 147–9, 188. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascal De Tullio Breakdown of academic impact, for papers by Jae Young So Breakdown of academic impact, for papers by Simon Wing Fai Mok Breakdown of academic impact, for papers by Samriddhi Shukla Breakdown of academic impact, for papers by John F. Schindler Breakdown of academic impact, for papers by Tianxin Yang Breakdown of academic impact, for papers by Veena Somasundaram Breakdown of academic impact, for papers by Sławomir Mańdziuk Breakdown of academic impact, for papers by Sung‐Po Hsu Breakdown of academic impact, for papers by Yang Sai
Rankless by CCL
2026